Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Last Week In Psychedelics:
Cybin Inc.
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector.
Palo Santo, a newly-created venture capital fund with an eye on psychedelic medicines, announced its official launch on Thursday.
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT f...
Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group in...
Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial publi...
Union Cannabis Group Names Adam Siskin New CFO Cannabis-focused product manufacturing and brand licensing company Union Cannab...
Psychedelics ETFs Are Gaining Traction Defiance ETFs launched the “Next Gen Altered Experience ETF,” the first U.S.-listed ETF...
